tiprankstipranks

Andrew Wolff Insider Profile

4 Followers
Andrew Wolff, SVP & CMO at Cytokinetics, holds 21.26K shares in Cytokinetics (Ticker: CYTK).
tipranks
Andrew Wolff

Andrew Wolff
Cytokinetics (CYTK)
SVP & CMO

Not Ranked
Andrew Wolff has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Andrew Wolff's holdings

Insider Roles

Cytokinetics
(CYTK)
SVP & CMO
Roles that Andrew Wolff holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Mar 13, 2015 - Mar 13, 2016
Return:+20.30%
The most profitable trade made by Andrew Wolff

Andrew Wolff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cytokinetics
Mar 02, 2017
SVP & CMO
Uninformative Buy
$1.39M
Success Rate for
CYTK
1 out of 1 profitable transactions on
CYTK
100%
Average Return for
CYTK
Average return per transaction on
CYTK
+20.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 05, 2013
Uninformative Buy
$41.91K
-
$0.00
Sep 05, 2012
Uninformative Buy
$24.04K
-
$0.00
Mar 13, 2015
Informative Sell
$170.64K
-
$6.30
+20.30%
Mar 02, 2017
Uninformative Buy
$0.00
-
$0.00
Mar 02, 2017
Uninformative Sell
$52.83K
-
$10.60
List of latest transactions for each holding click on a transaction to see Andrew Wolff's performance on stock

Andrew Wolff insider profile FAQ

What is the percentage of profitable transactions made by Andrew Wolff?
The percentage of profitable transactions made by Andrew Wolff is ―.
    What is the average return per transaction made by Andrew Wolff?
    The average return per transaction made by Andrew Wolff is ―.
      What stocks does Andrew Wolff hold?
      Andrew Wolff holds: CYTK stocks.
        What was Andrew Wolff’s latest transaction?
        Andrew Wolff latest transaction was an Uninformative Buy of ―.
          What was Andrew Wolff's most profitable transaction?
          Andrew Wolff’s most profitable transaction was an Informative Sell of CYTK stock on March 13, 2015. The return on the trade was 20.30%.
            What is Andrew Wolff's role in Cytokinetics?
            Andrew Wolff's role in Cytokinetics is SVP & CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.